Verdad Advisers, LP
BOSTON, MA
$104m in 210 US stocks at the end of 30 June 2026. The top 10 are 18.1% of the money. It changed about 49.6% of the portfolio this quarter.
Value
$104m
Stocks
210
Top 10 share
18.1%
Turnover
49.6%
What changed this quarter
New
Bought for the first time this quarter.
- AppleAAPL2.1% of the fund
- X4 PharmaceuticalsXFOR1.6% of the fund
- Jade BiosciencesJBIO1.2% of the fund
- Cisco SystemsCSCO1.2% of the fund
- Protara TherapeuticsTARA1.1% of the fund
- Tyra BiosciencesTYRA1.1% of the fund
- AlphabetGOOGL1.0% of the fund
- Nuvalent1.0% of the fund
- Verizon CommunicationsVZ0.8% of the fund
- Myers IndustriesMYE0.8% of the fund
- Enliven TherapeuticsELVN0.8% of the fund
- Universal Insurance HoldingsUVE0.8% of the fund
- PC ConnectionCNXN0.8% of the fund
- AllstateALL0.7% of the fund
- Celldex TherapeuticsCLDX0.7% of the fund
- Mativ HoldingsMATV0.7% of the fund
- GeronGERN0.6% of the fund
- Janux TherapeuticsJANX0.6% of the fund
- Avalo TherapeuticsAVTX0.6% of the fund
- Viemed HealthcareVMD0.6% of the fund
- Bristol-Myers SquibbBMY0.6% of the fund
- NvidiaNVDA0.5% of the fund
- UroGen PharmaURGN0.5% of the fund
- National HealthcareNHC0.5% of the fund
- APAAPA0.5% of the fund
Added
Bought more of a stock they already held.
- Acadia PharmaceuticalsACAD2.0% of the fund+21%
- ComcastCMCSA2.0% of the fund+104%
- Tenax TherapeuticsTENX1.7% of the fund+29%
- Slide Insurance HoldingsSLDE1.7% of the fund+197%
- AMN Healthcare ServicesAMN1.6% of the fund+4%
- Versant Media GroupVSNT1.5% of the fund+129%
- Netscout SystemsNTCT1.4% of the fund+125%
- Whitehawk TherapeuticsWHWK1.3% of the fund+161%
- Bloomin' BrandsBLMN1.1% of the fund+30%
- Edgewise TherapeuticsEWTX1.1% of the fund+109%
- Vera TherapeuticsVERA1.0% of the fund+131%
- Dianthus TherapeuticsDNTH0.9% of the fund+16%
- Oppenheimer HoldingsOPY0.9% of the fund+154%
- American Integrity Insurance GroupAII0.8% of the fund+3%
- Heritage Insurance HoldingsHRTG0.7% of the fund+8%
- TD SynnexSNX0.7% of the fund+92%
- Movado GroupMOV0.7% of the fund+75%
- Smart SandSND0.7% of the fund+16%
- Viridian TherapeuticsVRDN0.7% of the fund+24%
- Marcus & MillichapMMI0.7% of the fund+41%
- CytomX TherapeuticsCTMX0.6% of the fund+484%
- Net Lease Office PropertiesNLOP0.6% of the fund+146%
- OomaOOMA0.6% of the fund+70%
- Relmada TherapeuticsRLMD0.6% of the fund+85%
- Corbus Pharmaceuticals HoldingsCRBP0.6% of the fund+27%
Cut
Sold some of their stake.
- ZymeworksZYME1.7% of the fund-19%
- Contineum TherapeuticsCTNM1.3% of the fund-6%
- Nurix TherapeuticsNRIX1.2% of the fund-41%
- PAR Pacific HoldingsPARR1.1% of the fund-11%
- Aclaris TherapeuticsACRS0.9% of the fund-11%
- Bank of New York MellonBNY0.8% of the fund-36%
- Applied MaterialsAMAT0.8% of the fund-62%
- AdaptHealthAHCO0.7% of the fund-21%
- Revolution MedicinesRVMD0.7% of the fund-81%
- Design TherapeuticsDSGN0.7% of the fund-48%
- StoneX GroupSNEX0.6% of the fund-18%
- Zoom CommunicationsZM0.6% of the fund-67%
- Climb BioCLYM0.6% of the fund-68%
- TalkspaceTALK0.5% of the fund-40%
- AtaiBeckleyATAI0.5% of the fund-56%
- California ResourcesCRC0.5% of the fund-56%
- Hello GroupMOMO0.5% of the fund-43%
- Micron TechnologyMU0.5% of the fund-89%
- Jones Lang LasalleJLL0.5% of the fund-51%
- PROG HoldingsPRG0.4% of the fund-58%
- TeradyneTER0.4% of the fund-56%
- Arrow ElectronicsARW0.4% of the fund-15%
- ErascaERAS0.4% of the fund-32%
- Zura BioZURA0.4% of the fund-31%
- Lam ResearchLRCX0.4% of the fund-83%
Sold out
Sold their entire stake.
- State StreetSTT-100%
- AutohomeATHM-100%
- Cal-Maine FoodsCALM-100%
- Axsome TherapeuticsAXSM-100%
- ChevronCVX-100%
- NGL Energy Partners LPNGL-100%
- Terns Pharmaceuticals-100%
- General MotorsGM-100%
- Deckers OutdoorDECK-100%
- New York TimesNYT-100%
- HCI GroupHCI-100%
- ASA Gold & Precious MetalsASA-100%
- Ishares TRHYG-100%
- GravityGRVY-100%
- NewmontNEM-100%
- EmbectaEMBC-100%
- Academy Sports & OutdoorsASO-100%
- Millrose PropertiesMRP-100%
- Miami International HoldingsMIAX-100%
- Smart SH GlobalEM-100%
- Tarsus PharmaceuticalsTARS-100%
- AvnetAVT-100%
- CVS HealthCVS-100%
- BorgwarnerBWA-100%
- AxogenAXGN-100%
Holdings
- Belite BIOBLTE
- Share
- 2.0%
- Value
- $2m
- Shares
- 13,758
Held
- Nuvalent
- Share
- 1.0%
- Value
- $1m
- Shares
- 8,104
New
- Structure TherapeuticsGPCR
- Share
- 0.6%
- Value
- $608,349
- Shares
- 11,335
Held
- TalkspaceTALK
- Share
- 0.5%
- Value
- $547,310
- Shares
- 105,252
-40%
- AtaiBeckleyATAI
- Share
- 0.5%
- Value
- $530,589
- Shares
- 100,681
-56%
- Hello GroupMOMO
- Share
- 0.5%
- Value
- $491,173
- Shares
- 84,685
-43%
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| AppleAAPL | 2.1% | $2m | 7,445 | New |
| Belite BIOBLTE | 2.0% | $2m | 13,758 | Held |
| Acadia PharmaceuticalsACAD | 2.0% | $2m | 82,629 | +21% |
| ComcastCMCSA | 2.0% | $2m | 84,569 | +104% |
| Chatham Lodging TrustCLDT | 1.8% | $2m | 140,000 | Held |
| Tenax TherapeuticsTENX | 1.7% | $2m | 123,174 | +29% |
| Slide Insurance HoldingsSLDE | 1.7% | $2m | 91,070 | +197% |
| ZymeworksZYME | 1.7% | $2m | 66,688 | -19% |
| AMN Healthcare ServicesAMN | 1.6% | $2m | 51,906 | +4% |
| X4 PharmaceuticalsXFOR | 1.6% | $2m | 352,093 | New |
| Versant Media GroupVSNT | 1.5% | $2m | 43,503 | +129% |
| Netscout SystemsNTCT | 1.4% | $1m | 33,128 | +125% |
| Whitehawk TherapeuticsWHWK | 1.3% | $1m | 301,483 | +161% |
| Johnson & JohnsonJNJ | 1.3% | $1m | 5,384 | Held |
| Contineum TherapeuticsCTNM | 1.3% | $1m | 81,014 | -6% |
| Jade BiosciencesJBIO | 1.2% | $1m | 56,384 | New |
| Cisco SystemsCSCO | 1.2% | $1m | 10,307 | New |
| Nurix TherapeuticsNRIX | 1.2% | $1m | 49,511 | -41% |
| Protara TherapeuticsTARA | 1.1% | $1m | 312,249 | New |
| Bloomin' BrandsBLMN | 1.1% | $1m | 130,000 | +30% |
| Tyra BiosciencesTYRA | 1.1% | $1m | 36,003 | New |
| PAR Pacific HoldingsPARR | 1.1% | $1m | 20,000 | -11% |
| Edgewise TherapeuticsEWTX | 1.1% | $1m | 27,234 | +109% |
| AlphabetGOOGL | 1.0% | $1m | 2,900 | New |
| CartersCRI | 1.0% | $1m | 25,000 | Held |
| Vera TherapeuticsVERA | 1.0% | $1m | 23,487 | +131% |
| Nuvalent | 1.0% | $1m | 8,104 | New |
| Dianthus TherapeuticsDNTH | 0.9% | $980,844 | 10,062 | +16% |
| Aclaris TherapeuticsACRS | 0.9% | $927,189 | 175,272 | -11% |
| Oppenheimer HoldingsOPY | 0.9% | $915,348 | 8,673 | +154% |
| Verizon CommunicationsVZ | 0.8% | $886,515 | 20,938 | New |
| Myers IndustriesMYE | 0.8% | $865,095 | 24,500 | New |
| Enliven TherapeuticsELVN | 0.8% | $860,568 | 16,957 | New |
| Universal Insurance HoldingsUVE | 0.8% | $850,279 | 20,558 | New |
| Bank of New York MellonBNY | 0.8% | $831,218 | 5,748 | -36% |
| PC ConnectionCNXN | 0.8% | $809,021 | 11,084 | New |
| American Integrity Insurance GroupAII | 0.8% | $794,212 | 42,178 | +3% |
| Applied MaterialsAMAT | 0.8% | $787,347 | 1,089 | -62% |
| AdaptHealthAHCO | 0.7% | $781,500 | 75,000 | -21% |
| AllstateALL | 0.7% | $780,205 | 3,279 | New |
| Celldex TherapeuticsCLDX | 0.7% | $770,396 | 20,704 | New |
| Revolution MedicinesRVMD | 0.7% | $759,046 | 4,053 | -81% |
| Heritage Insurance HoldingsHRTG | 0.7% | $745,236 | 28,575 | +8% |
| TD SynnexSNX | 0.7% | $743,205 | 2,780 | +92% |
| Movado GroupMOV | 0.7% | $737,534 | 18,762 | +75% |
| Smart SandSND | 0.7% | $714,847 | 142,684 | +16% |
| Viridian TherapeuticsVRDN | 0.7% | $711,323 | 38,722 | +24% |
| Design TherapeuticsDSGN | 0.7% | $688,150 | 47,557 | -48% |
| Marcus & MillichapMMI | 0.7% | $684,867 | 21,972 | +41% |
| Mativ HoldingsMATV | 0.7% | $681,300 | 90,000 | New |
| StoneX GroupSNEX | 0.6% | $673,317 | 5,682 | -18% |
| CytomX TherapeuticsCTMX | 0.6% | $661,526 | 176,407 | +484% |
| Net Lease Office PropertiesNLOP | 0.6% | $654,344 | 58,791 | +146% |
| GeronGERN | 0.6% | $632,577 | 494,201 | New |
| OomaOOMA | 0.6% | $630,608 | 32,810 | +70% |
| Rocky BrandsRCKY | 0.6% | $629,075 | 15,254 | Held |
| Janux TherapeuticsJANX | 0.6% | $620,329 | 40,386 | New |
| Zoom CommunicationsZM | 0.6% | $614,959 | 7,125 | -67% |
| Structure TherapeuticsGPCR | 0.6% | $608,349 | 11,335 | Held |
| Avalo TherapeuticsAVTX | 0.6% | $606,643 | 32,827 | New |
| Mistras GroupMG | 0.6% | $603,169 | 34,526 | Held |
| Viemed HealthcareVMD | 0.6% | $602,821 | 52,879 | New |
| Relmada TherapeuticsRLMD | 0.6% | $601,998 | 86,994 | +85% |
| Climb BioCLYM | 0.6% | $601,340 | 46,115 | -68% |
| Corbus Pharmaceuticals HoldingsCRBP | 0.6% | $596,596 | 63,603 | +27% |
| Bristol-Myers SquibbBMY | 0.6% | $591,354 | 10,263 | New |
| Security National FinancialSNFCA | 0.6% | $581,400 | 60,000 | Held |
| Usana Health SciencesUSNA | 0.5% | $556,552 | 26,068 | +53% |
| TalkspaceTALK | 0.5% | $547,310 | 105,252 | -40% |
| NvidiaNVDA | 0.5% | $547,246 | 2,735 | New |
| UroGen PharmaURGN | 0.5% | $531,392 | 14,440 | New |
| AtaiBeckleyATAI | 0.5% | $530,589 | 100,681 | -56% |
| California ResourcesCRC | 0.5% | $528,700 | 10,000 | -56% |
| Cullinan TherapeuticsCGEM | 0.5% | $527,853 | 28,987 | +130% |
| iBioIBIO | 0.5% | $523,122 | 298,927 | +431% |
| ViatrisVTRS | 0.5% | $516,100 | 32,500 | Held |
| InnovAge HoldingINNV | 0.5% | $499,347 | 42,139 | +33% |
| Hello GroupMOMO | 0.5% | $491,173 | 84,685 | -43% |
| PMV PharmaceuticalsPMVP | 0.5% | $485,564 | 362,361 | +101% |
| National HealthcareNHC | 0.5% | $485,071 | 2,295 | New |
| Cirrus LogicCRUS | 0.5% | $484,950 | 3,265 | Held |
| Micron TechnologyMU | 0.5% | $483,648 | 419 | -89% |
| Jones Lang LasalleJLL | 0.5% | $481,042 | 1,552 | -51% |
| APAAPA | 0.5% | $474,284 | 14,562 | New |
| RMR GroupRMR | 0.4% | $461,843 | 22,496 | New |
| Fulcrum TherapeuticsFULC | 0.4% | $458,320 | 125,224 | New |
| PROG HoldingsPRG | 0.4% | $437,295 | 9,382 | -58% |
| SepternaSEPN | 0.4% | $434,365 | 12,970 | New |
| BioAge LabsBIOA | 0.4% | $426,327 | 17,394 | +14% |
| TeradyneTER | 0.4% | $424,812 | 878 | -56% |
| Arrow ElectronicsARW | 0.4% | $421,698 | 1,976 | -15% |
| Ingles MarketsIMKTA | 0.4% | $419,338 | 4,734 | New |
| ErascaERAS | 0.4% | $411,467 | 22,460 | -32% |
| Viant TechnologyDSP | 0.4% | $403,601 | 31,880 | New |
| QualcommQCOM | 0.4% | $399,331 | 2,161 | New |
| Shattuck LabsSTTK | 0.4% | $397,183 | 57,231 | +328% |
| Zura BioZURA | 0.4% | $394,822 | 66,919 | -31% |
| Lam ResearchLRCX | 0.4% | $386,964 | 893 | -83% |
| SavaraSVRA | 0.4% | $380,435 | 61,759 | -52% |
| Maze TherapeuticsMAZE | 0.4% | $376,521 | 12,618 | New |
Showing the largest 100 of 210.
Over time and by industry
Value over time
Dec '25
Jun '26
Value is up 19.5% since 31 December 2025.
Where the money is
Health care46.2%
Technology16.7%
Financial services8.7%
Media & telecom6.1%
Retail & consumer4.6%
Industrials3.7%
Real estate3.5%
Materials2.2%
Energy2.0%
Everyday goods1.1%
Other5.1%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.